PiezoMotor
PiezoMotor develops proprietary piezo-based motion technology for nanometer-level precision in compact, energy-efficient formats.

Acuvi develops, manufactures, and sells miniature actuators, motors that create force or motion, for medical, life-science, semiconductor, and advanced-industrial customers.
acuvi.comCrawled Nov 16, 2026
PiezoMotor develops proprietary piezo-based motion technology for nanometer-level precision in compact, energy-efficient formats.
Sensapex provides high-precision micromanipulation and control systems for reproducible results in demanding research applications.
TPA Motion designs and delivers custom motion systems to reduce complexity, accelerate development, and ensure reliable performance in demanding applications.
Acuvi’s U.S. subsidiary TPA Motion has supplied Intuitive Surgical, a leading manufacturer of surgical robots, for eight years, with planned 2024 invoicing of approximately 20 million SEK.
Acuvi AB’s annual general meeting on May 22, 2024, approved the 2023 financial statements and decided no dividend would be distributed.
Acuvi AB shareholders are summoned to an annual general meeting on May 22, 2024, at 10:00 at Stationsgatan 23 in Uppsala, with registration starting at 09:45.
Acuvi AB shareholders are summoned to an annual general meeting on June 10, 2025, at 10:00 at Stationsgatan 23 in Uppsala, with registration starting at 09:45.
Acuvi’s subsidiary TPA Motion received a $0.5 million order from a U.S.-based supplier of passive optical components for datacenters, telecom, and industrial networks, with deliveries planned for 2027.
Acuvi offers career opportunities in precision technologies, supporting innovation in performance-critical applications across Sweden, Finland, and the United States.
Acuvi encourages unsolicited applications from professionals whose expertise aligns with its mission in precision motion technologies.
Acuvi seeks a technically skilled Technical Sales Specialist for North America, requiring extensive travel to drive growth and innovation in precision motion.
Olof Stranding has served as CEO of Acuvi since 2013, with prior experience in audit at KPMG and business-oriented controlling roles.
Adam Dahlberg. Chairman since 1999. Swedish technology investor within new materials, life science, medtech and software
Mission & Vision Precision where it matters most Across MedTech, Life Science, Semiconductor, Space, Energy and Advanced Industrial markets, systems are becoming increasingly complex, miniaturized and performance-critical. As technologies advance, the tolerance for error continues to decrease. At these levels, even the smallest deviation can impact system performance, reduce yield, or introduce operational and clinical...
Acuvi operates in fast-growing markets with high demand for its unique motion technology solutions.
Contact Acuvi for engineering or other inquiries.
Acuvi enables precision motion in MedTech, Life Science, Semiconductors, and Advanced Industry, supporting next-generation systems requiring miniaturization and reliability.
Acuvi AB partners with a Japanese precision positioning systems manufacturer to globally market and sell motorized precision stages under the **PiezoMotor** brand. The collaboration grants Acuvi exclusive rights to distribute the full product line, expanding its offerings in high-precision motion control. The agreement targets industries requiring sub-micron positioning accuracy, including semiconductor manufacturing and scientific research.
Acuvi reports **SEK 50.1 million in net sales** for Q2 2026, down from SEK 47.2 million in the prior period. The company records an **EBITDA loss of SEK 4.3 million** (versus a SEK 12.0 million profit) and an **EBIT loss of SEK 9.3 million**, reflecting an **18% negative margin** compared to a 16% positive margin previously. Operating performance declines despite maintaining revenue growth.
Acuvi AB appoints Jens Lagergren as its new Chief Financial Officer (CFO). Lagergren previously served as a financial consultant for the company since March 2026. His role transitions to full-time employment starting June 2026.
Acuvi secures a **$1.9 million** order from a repeat US defense customer for its **high-precision motion technology**. Deliveries will span the next **30 months**, continuing the company’s engagement with the defense sector. The contract reflects demand for Acuvi’s specialized hardware in military applications.
Acuvi secures a **$1.3 million order** from a repeat US defense customer for its high-precision motion technology. Deliveries will span the next **24 months**, supporting the company’s focus on defense-sector applications. The contract reflects continued demand for Acuvi’s specialized hardware in military and aerospace systems.
Acuvi supplies a Formula 1 team with its piezo-based motion technology, expanding into elite motorsport. The company leverages precision engineering to enhance performance in high-speed racing applications. This marks Acuvi’s first direct involvement in Formula 1.
Acuvi reports **SEK 204 million in net sales for 2025**, marking an **18% growth in constant currencies**. The company’s adjusted EBITDA reached **SEK 33 million**. Management sets a **2026 EBITDA target of SEK 37–50 million** as part of its financial strategy.
ACUVI AB launches a Japanese subsidiary and opens a Tokyo sales office to expand its market reach. The move targets growth in Japan’s medical technology, semiconductor, and automation sectors. The company strengthens its regional support infrastructure to serve Asian industrial customers.